Form 8-K - Current report:
SEC Accession No. 0000950170-25-113023
Filing Date
2025-09-04
Accepted
2025-09-04 16:01:28
Documents
10
Period of Report
2025-08-29
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K eq-20250829.htm   iXBRL 8-K 46223
  Complete submission text file 0000950170-25-113023.txt   155160

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT eq-20250829.xsd EX-101.SCH 27867
12 EXTRACTED XBRL INSTANCE DOCUMENT eq-20250829_htm.xml XML 4704
Mailing Address 2223 AVENIDA DE LA PLAYA SUITE 105 LA JOLLA CA 92037
Business Address 2223 AVENIDA DE LA PLAYA SUITE 105 LA JOLLA CA 92037 (858) 412-5302
Equillium, Inc. (Filer) CIK: 0001746466 (see all company filings)

EIN.: 821554746 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)